Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
67,719.38
(
-1.70%
)
News Focus
News Focus

Replies to post #196714 on Biotech Values

Replies to #196714 on Biotech Values
icon url

DewDiligence

11/03/15 9:54 AM

#196776 RE: DewDiligence #196714

SHPG/DYAX—Criteria for CVR to pay $4/sh:

• DX-2930 full approval (not Subpart H accelerated approval) by 12/31/19; and
• No REMS; and
• No black-box warning in FDA label.

H/t @AndyBiotech.